GlassScriptPhysician profile
Jennifer Sullivan
NPI 1912315474
$723.62
in general payments reported to CMS, 2019-2025
10 companies · $157 in 2025
The $157 reported for 2025 was more than what a typical Acute Care (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $137).
See the full distribution for Acute Care (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $99.00 · 2023: $37.82 · 2024: $430 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $385 · Food and Beverage: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $384.96 |
| Food and Beverage | $239.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $165.29 | 2023-2024 | |
| Stryker Corporation | $101.69 | 2024 | Procuity |
| Amgen INC. | $99.00 | 2022 | |
| Janssen Biotech, INC. | $87.99 | 2024 | Darzalex |
| Daiichi Sankyo INC. | $79.99 | 2025 | Enhertu |
| Astellas Pharma US INC | $75.99 | 2024 | |
| Genentech USA, INC. | $51.34 | 2025 | Polivy |
| C. R. Bard, INC. & Subsidiaries | $25.80 | 2025 | Accucath |
| Medtronic, INC. | $23.01 | 2024 | Endo Gia Ultra |
| Janssen Pharmaceuticals, INC | $13.52 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.